Created On: 2020-07-15
Record Count: 7
- Personal Care Products
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27978
The Licensor for barrier repair technology is a technology that is a specific combination of ceramides, cholesterol and fatty acids which are able to create a human-like skin barrier and thus provide patients with a more normal skin barrier function.
The Barrier Repair platform represents near term revenue opportunities for prescription skin care products to treat a variety of skin disorders all characterized by a disrupted skin barrier. In April 2006, the licensor received clearance from the United States Food and Drug Administration (FDA) to market EpiCeramÂ® their first commercial product using the Barrier Repair technology. EpiCeramÂ® is a prescription-only topical cream intended to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatoses including atopic dermatitis (eczema), irritant contact dermatitis, and radiation dermatitis.
IPSCIO Record ID: 6219
The Licensee has the right to use the Barrier Repair technology (skin care products to treat a variety of skin disorders all characterized by a disrupted skin barrier) to develop and market cosmetic, non-prescription products.
â€œLicensed Patentâ€ means U.S. Patent No. 5,643,899, all reissues.
â€œTriceramâ„¢â€ means a ceramide dominated formulation of the Licensed Product.
IPSCIO Record ID: 2271
The Skin Fresh treatment program avoids the use of prescription drugs taken internally, and includes a regimen and the topical application of FDA approved antibiotics.
IPSCIO Record ID: 29106
IPSCIO Record ID: 1884
IPSCIO Record ID: 1724
IPSCIO Record ID: 2279